282 related articles for article (PubMed ID: 29428700)
1. Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysis.
Semenkovich TR; Panni RZ; Hudson JL; Thomas T; Elmore LC; Chang SH; Meyers BF; Kozower BD; Puri V
J Thorac Cardiovasc Surg; 2018 May; 155(5):2221-2230.e1. PubMed ID: 29428700
[TBL] [Abstract][Full Text] [Related]
2. Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction Therapy.
Samson P; Puri V; Robinson C; Lockhart C; Carpenter D; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Meyers B; Crabtree T
Ann Thorac Surg; 2016 Jun; 101(6):2102-11. PubMed ID: 27083246
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for patients with pathologic node-positive esophageal cancer after induction chemotherapy is associated with improved survival.
Samson P; Puri V; Lockhart AC; Robinson C; Broderick S; Patterson GA; Meyers B; Crabtree T
J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1725-1735. PubMed ID: 30054137
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options.
Mota FC; Cecconello I; Takeda FR; Tustumi F; Sallum RAA; Bernardo WM
Int J Surg; 2018 Jun; 54(Pt A):176-181. PubMed ID: 29730075
[TBL] [Abstract][Full Text] [Related]
5. What is the optimal interval between chemoradiation and esophagectomy?
Martin LW
Semin Thorac Cardiovasc Surg; 2012; 24(2):87-9. PubMed ID: 22920522
[TBL] [Abstract][Full Text] [Related]
6. Upfront surgery and pathological stage-based adjuvant chemoradiation strategy in locally advanced esophageal squamous cell carcinoma.
Chen HS; Hsu PK; Liu CC; Wu SC
Sci Rep; 2018 Feb; 8(1):2180. PubMed ID: 29391589
[TBL] [Abstract][Full Text] [Related]
7. Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
Speicher PJ; Ganapathi AM; Englum BR; Hartwig MG; Onaitis MW; D'Amico TA; Berry MF
J Thorac Oncol; 2014 Aug; 9(8):1195-201. PubMed ID: 25157773
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.
Bergeron EJ; Lin J; Chang AC; Orringer MB; Reddy RM
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):765-71: Discussion 771-3. PubMed ID: 24314788
[TBL] [Abstract][Full Text] [Related]
9. Esophagectomy after chemoradiation: who and when to operate.
Kim JY; Hofstetter WL
Semin Thorac Cardiovasc Surg; 2012; 24(4):288-93. PubMed ID: 23465677
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic ultrasound for early stage esophageal adenocarcinoma: implications for staging and survival.
Crabtree TD; Yacoub WN; Puri V; Azar R; Zoole JB; Patterson GA; Krupnick AS; Kreisel D; Meyers BF
Ann Thorac Surg; 2011 May; 91(5):1509-15; discussion 1515-6. PubMed ID: 21435632
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Chemoradiation Versus Upfront Esophagectomy in Clinical Stage II and III Esophageal Squamous Cell Carcinoma.
Hsu PK; Chen HS; Liu CC; Wu SC
Ann Surg Oncol; 2019 Feb; 26(2):506-513. PubMed ID: 30430325
[TBL] [Abstract][Full Text] [Related]
12. Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all?
Hsu PK; Chien LI; Huang CS; Hsieh CC; Wu YC; Hsu WH; Chou TY
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):460-6. PubMed ID: 23728085
[TBL] [Abstract][Full Text] [Related]
13. Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma.
Levinsky NC; Wima K; Morris MC; Ahmad SA; Shah SA; Starnes SL; Van Haren RM;
J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2555-2566. PubMed ID: 31767364
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma.
Groth SS; Burt BM; Farjah F; Smaglo BG; Sada YH; Sugarbaker DJ; Massarweh NN
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1682-1693.e1. PubMed ID: 30711279
[TBL] [Abstract][Full Text] [Related]
15. Effect of thoracic versus cervical anastomosis on anastomotic leak among patients who undergo esophagectomy after neoadjuvant chemoradiation.
Chidi AP; Etchill EW; Ha JS; Bush EL; Yang SC; Battafarano RJ; Broderick SR
J Thorac Cardiovasc Surg; 2020 Oct; 160(4):1088-1095. PubMed ID: 32299695
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant Therapy Vs Upfront Surgery for Clinical T2N0 Esophageal Cancer: A Systematic Review.
Kidane B; Korst RJ; Weksler B; Farrell A; Darling GE; Martin LW; Reddy R; Sarkaria IS
Ann Thorac Surg; 2019 Sep; 108(3):935-944. PubMed ID: 31077657
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
Tiesi G; Park W; Gunder M; Rubio G; Berger M; Ardalan B; Livingstone A; Franceschi D
J Surg Res; 2017 Aug; 216():65-72. PubMed ID: 28807215
[TBL] [Abstract][Full Text] [Related]
19. The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation.
Spector R; Zheng Y; Yeap BY; Wee JO; Lebenthal A; Swanson SJ; Marchosky DE; Enzinger PC; Mamon HJ; Lerut A; Odze R; Srivastava A; Agoston AT; Tippayawang M; Bueno R;
Semin Thorac Cardiovasc Surg; 2015; 27(2):205-15. PubMed ID: 26686448
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of endoscopic ultrasound in the diagnosis of T2N0 esophageal cancer.
Tekola BD; Sauer BG; Wang AY; White GE; Shami VM
J Gastrointest Cancer; 2014 Sep; 45(3):342-6. PubMed ID: 24788081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
